Oligodendroglioma
- PMID: 32644610
- Bookshelf ID: NBK559184
Oligodendroglioma
Excerpt
Oligodendroglioma (OG) is a diffusely infiltrating glioma representing approximately 5% of all primary intracranial tumors. These tumors often involve the cortical gray and the white matter and are most commonly located in the frontal lobes. Historically, the OG was diagnosed by the histological appearance of the tumor. However, in 2016, the World Health Organization (WHO) changed the criteria for classifying central nervous system (CNS) tumors to include a phenotypic and genotypic analysis. OGs are generally low-grade WHO grade II neoplasms that are slow-growing tumors and have a favorable response to treatment compared to other gliomas. The grade III anaplastic OG is a highly malignant form of the tumor that has an unfavorable prognosis and may occur de novo or as a malignant transformation from the lower grade OG.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
- Continuing Education Activity
- Introduction
- Etiology
- Epidemiology
- Pathophysiology
- Histopathology
- History and Physical
- Evaluation
- Treatment / Management
- Differential Diagnosis
- Prognosis
- Complications
- Deterrence and Patient Education
- Pearls and Other Issues
- Enhancing Healthcare Team Outcomes
- Review Questions
- References
References
-
- Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016 Jun;131(6):803-20. - PubMed
-
- Anderson MD, Gilbert MR. Treatment recommendations for anaplastic oligodendrogliomas that are codeleted. Oncology (Williston Park) 2013 Apr;27(4):315-20, 322. - PubMed
-
- Cairncross G, Jenkins R. Gliomas with 1p/19q codeletion: a.k.a. oligodendroglioma. Cancer J. 2008 Nov-Dec;14(6):352-7. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous